<DOC>
	<DOCNO>NCT00711165</DOCNO>
	<brief_summary>A post-marketing study look effect Asmanex marker airway inflammation .</brief_summary>
	<brief_title>Mometasone Markers Airway Inflammation</brief_title>
	<detailed_description>Patients asthma treat anti-inflammatory medication study . This parallel , randomized , placebo-controlled study investigate effect Asmanex marker airway inflammation include exhale nitric oxide , airway reactivity , FEV1 nitrates/nitrites pH exhale breath condensate .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Asthma nonsmoker FEV1 least 60 % predicted Pregnancy lactation Corticosteroid use past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Nitric Oxide</keyword>
	<keyword>Exhaled Breath Condensate</keyword>
	<keyword>Methacholine Challenge</keyword>
</DOC>